Key result
Trans-septal endocardial LV lead implantation improves clinical response but is linked to 9% stroke incidence.
Why the study?
When conventional trans-venous CS lead placement fails, trans-septal endocardial LV lead placement is an alternative, but its use is limited by a lack of evidence, practice uptake, and clinical trials.
Does trans-septal endocardial left ventricle lead implantation improve clinical and echocardiographic outcomes in patients with heart failure and challenging coronary sinus anatomy?
Cohort
No
Does trans-septal endocardial left ventricle lead implantation improve clinical and echocardiographic outcomes in patients with heart failure and challenging coronary sinus anatomy?
Answers are grounded in this paper and cite their sources.
Trans-septal endocardial left ventricular lead implantation improves echocardiographic and clinical parameters in heart failure patients with challenging coronary sinus anatomy, but carries a significant 9% risk of stroke.
BACKGROUND: When conventional trans-venous CS lead placement fails, trans-septal endocardial left ventricle lead placement is an alternative technique used to capture the left ventricle endocardially; however, its use is limited due to a lack of evidence, practice uptake, and clinical trials. METHODS: In this single-center cohort study, we evaluated the efficiency of the procedure, post-procedural complication rate, rate of thromboembolic events, overall survival rate, and changes in the echocardiographic parameters, brain natriuretic peptide (BNP) level, and New York Heart Association (NYHA) class, both before and after TSLV lead implantation. RESULTS: The TSLV lead implant is safe and improves EF, LVEDV, LVESV, and LVIDd. It significantly reduces the NTproBNP levels and the NYHA class; however, the rate of stroke incidence remains high, at 9%. CONCLUSIONS: We demonstrated a high success rate of trans-septal left ventricular endocardial lead implantation, LV reverse remodeling was noted, and patients had a favorable clinical response; however, there was an increased risk of systemic embolization after the trans-septal LV lead implant.
No takes yet. Share an insight, caveat, or question.
Farhangee et al. (2024) conducted a cohort in Heart failure with challenging coronary sinus anatomy. Trans-septal endocardial left ventricle lead implant was evaluated on Stroke incidence. Trans-septal endocardial left ventricle lead implantation improved echocardiographic parameters and clinical response, but was associated with a high stroke incidence of 9%.
Synapse has enriched 10 related papers. Consider them for comparative context: